Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Evans, MA
Brian Charles Evans, Marshfield, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110278137 | SLOPE PLATE CARROUSEL CARRIAGE FRAME - The present disclosure is directed to a carriage frame that is used in a slope plate carriage carrousel system that may be found in airports for conveying luggage for passengers to claim. A slope plate carrousel carriage frame according to an embodiment of the present disclosure includes a slope plate support member. The slope plate support member is configured to support a slope plate of the carrousel system. A lower carriage is coupled to the slope plate support member. The carriage frame also includes at least one removable connecting link. | 11-17-2011 |
Catherine A. Evans, Someville, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120088738 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE - Provided herein are compounds of formula (I): or pharmaceutically acceptable salts, solvates or prodrugs thereof or mixtures thereof, wherein Z | 04-12-2012 |
Catherine A. Evans, Somerville, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090099131 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). | 04-16-2009 |
| 20110028478 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provides isoxazoline FAAH inhibitors of the formula (I): | 02-03-2011 |
| 20110028482 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provides isoxazoline FAAH inhibitors of the formula (I): | 02-03-2011 |
| 20110034437 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provides isoxazoline FAAH inhibitors of the formula (I): | 02-10-2011 |
| 20110172186 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. | 07-14-2011 |
| 20110224171 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). | 09-15-2011 |
| 20110230440 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE - The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). | 09-22-2011 |
| 20120059000 | CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS FOR KINASE MODULATION - Chemical compounds that modulate kinase activity, including PI3 kinase activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. | 03-08-2012 |
| 20120122838 | HETEROCYCLIC COMPOUNDS AND USES THEREOF - Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. | 05-17-2012 |
Christopher C. Evans, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120039560 | ALL-OPTICAL LOGIC GATES AND METHODS FOR THEIR FABRICATION - The present invention provides optical devices that employ nonlinear optical effects for processing optical signals. For example, such an optical device can include a nano-sized interferometric component that provides an optical output signal via interference of two input signals subsequent to their asymmetric nonlinear phase accumulation. The interferometric element can have a variety of configurations, such as Sagnac, Mach-Zehnder or Michelson configurations. | 02-16-2012 |
Christopher H. Evans, Cohasset, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110280935 | VIRAL AND NON-VIRAL VECTORS AS VEHICLES FOR DELIVERING TRANSGENES FOR TREATING BONE PATHOLOGIES - The present invention relates to a method for treating bone pathologies comprising delivering a viral or non-viral delivery vehicle comprising genetic information (e.g. a transgene) encoding a therapeutic osteoinductive factor to target cells in vivo enabling the cells to produce the osteoinductive factor at the site of the bone pathology. The delivery is achieved by a simplified method which does not require cumbersome ex vivo techniques or additional matrix or scaffolding agents. Such viral and non-viral delivery vehicles of the present invention are derived from the following nonlimiting examples: adenoviruses, adeno-associated viruses, retroviruses, herpes simplex viruses, liposomes, and plasmids. The osteoinductive factors include, but are not limited to, growth factors, cytokines, growth factor inhibitors and cytokine inhibitors. | 11-17-2011 |
Conor L. Evans, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090059360 | SYSTEM AND METHOD FOR SELF-INTERFERENCE FLUORESCENCE MICROSCOPY, AND COMPUTER-ACCESSIBLE MEDIUM ASSOCIATED THEREWITH - Exemplary apparatus and/or method can be provided using which, it is possible to provide information associated with at least one portion of a sample. For example, at least one electro-magnetic radiation received from the at least one portion of the sample can be separated into a plurality of first radiations, one of the first radiations having a phase delay that is different from a phase delay of another of the first radiations. In addition, at least one of the first radiations can be received and separated into second radiations according to wavelengths of the received at least one of the first radiations. Further, it is possible to detect the second radiations and generate information regarding a position of the at least one portion of the sample as a function of at least one characteristic of at least one interference of the first radiations. According to another exemplary embodiment, it is possible to provide system, method and computer accessible medium, in which data associated with first radiations can be obtained, and the information regarding a position of the at least one portion of the sample may be generated. Such information can be generated based on the data by separating second radiations associated with the portion(s) of the sample according to wavelengths of at least one of the second radiations. For example, one of the second radiations can have a phase delay that is different from a phase delay of another one of the second radiations, and the second radiations may be interfering. | 03-05-2009 |
David A. Evans, Seekonk, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120127632 | EXTENDED LIFE CAPACITORS - Capacitors employing liquid or gel electrolytes have their useful lifetime significantly extended by including, in the electrolyte, a binary mixture of transition metal ion species. Each species has at least two distinct oxidation states when dissolved in the electrolyte. The interaction of the mixture of ion species reduces the potential of the cathode and maintains the potential of the cathode below the hydrogen potential to prevent the reduction of hydrogen ions and the formation of hydrogen. The binary mixture of transition metal species reduces the cathode potential by oxidation of the transition metal species at the anode and reduction of the transition metal species at the cathode. Thus, the rate of decrease in capacitance, increase in equivalent series resistance, and swelling of the capacitor are suppressed. In addition, the ratio of capacitor aging to the quantity of charge passed by the capacitor is decreased by at least a factor of two as compared to previous known extended life capacitors. | 05-24-2012 |
Joseph Romney Evans, Newton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110099122 | SYSTEM AND METHOD FOR PROVIDING CUSTOMERS WITH PERSONALIZED INFORMATION ABOUT PRODUCTS - Embodiments of the invention may provide a personalized fit prediction to a particular consumer about a particular product. Personalization of the fit prediction may be accomplished by processing various types of data, including data about consumers, products, and previous purchases by consumers. For example, this data may be used to generate a model (e.g., set of rules), which can then be applied to predict whether and/or how well a particular product will suit a particular consumer. | 04-28-2011 |
| 20120030062 | ENABLING PROXY SHOPPING - Some embodiments of the invention enable a buyer to shop for and purchase items for a recipient with confidence. For example, some embodiments of the invention enable a recipient to create a profile that may be accessed to make recommendations to a buyer on items deemed likely to suit the recipient in any of numerous ways (e.g., those deemed likely to fit the recipient, be age-appropriate, reflect the recipient's style, suit the recipient's fit preferences, conform to the recipient's measurements, etc.). In some embodiments, a recipient may indicate that certain, or all, aspects of the profile be kept private, so that the buyer need not know information about the recipient such as his/her body measurements, fit preferences, style preferences, and/or other information to be able to shop confidently for the recipient. | 02-02-2012 |
Llewelyn John Evans, Wilbraham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090278843 | COMPUTER AIDED DESIGN OF THREE-DIMENSIONAL CARTONS WITH CURVED CREASES - A method, a computer readable medium with instructions to execute a method, and a carton designed using a method. The method includes accepting a specification of a carton made up of a substrate and having at least one curved crease. The method further includes for a curved crease, accepting a folding angle at any point of the crease; and automatically calculating at least one shape of the folded carton in order to determine a three-dimensional model of the folded carton. | 11-12-2009 |
Morgan Evans, Manchester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090162953 | PREDICTING DOSE REPEATABILITY IN AN ION IMPLANTATION - An approach for predicting dose repeatability in an ion implantation is described. In one embodiment, an ion source is tuned to generate an ion beam with desired beam current. Beam current measurements are obtained from the tuned ion beam. The dose repeatability is predicted for the ion implantation as a function of the beam current measurements. | 06-25-2009 |
Morgan D. Evans, Manchester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090242808 | TECHNIQUES FOR IMPROVED UNIFORMITY TUNING IN AN ION IMPLANTER SYSTEM - Techniques for uniformity tuning in an ion implanter system are disclosed. In one particular exemplary embodiment, the techniques may be realized as a method for ion beam uniformity tuning. The method may comprise generating an ion beam in an ion implanter system. The method may also comprise measuring a first ion beam current density profile along an ion beam path. The method may further comprise measuring a second ion beam current density profile along the ion beam path. In addition, the method may comprise determining a third ion beam current density profile along the ion beam path based at least in part on the first ion beam current density profile and the second ion beam current density profile. | 10-01-2009 |
Neil D. Evans, North Chelmsford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100114850 | Event recording with local event record locking - Systems, methods, and other embodiments associated with event recording are described. One example method includes locally locking a record in an event data store corresponding to an event having a same event type as a given event when a prior occurrence of the given event has not yet been recorded. The event data store is updated to record the given event while the record is locked. One example system includes an event data store configured to store records corresponding to events, an event recorder configured to record event data in the event data store and a local lock actuable by the event recorder. The event recorder is configured to update the locked record to correspond to a received event. | 05-06-2010 |
Paul Evans, Allston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110104614 | Self-imageable film forming polymer, compositions thereof and devices and structures made therefrom - Embodiments in accordance with the present invention encompass self-imageable film forming compositions that comprise norbornene-type polymers and that can be formulated to be either positive tone imaging or negative tone. The films formed thereby are useful in the forming of microelectronic and optoelectronics devices. | 05-05-2011 |
Robert Evans, Sturbridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090116826 | INTER-AXIAL INLINE FLUID HEATER - An inter-axial inline fluid heater is presented. The inter-axial inline fluid heater includes an outer retaining sheath defining a first area, and an interior flow tube disposed within the outer sheath and capable of having fluid flow therethrough. Further, the inter-axial inline fluid heater includes a resistance wire disposed between the interior flow tube and the outer retaining sheath, the resistance wire capable of producing heat for heating a fluid passing through the interior flow tube when power is applied to the resistance wire. Also includes is a dielectric heat transfer material disposed between the interior flow tube and the outer retaining sheath and surrounding at least a portion of the resistance wire. | 05-07-2009 |
Robert Evans, Worcester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120061373 | AXIAL RESISTANCE SHEATHED HEATER - An axial resistance sheathed heater is presented. The axial resistance sheathed heater includes a retaining sheath having a first end and a second end and a resistance wire completely disposed within the retaining sheath. The heater further includes a first conductor rod partially disposed within the retaining sheath and extending beyond the first end of the retaining sheath, the first conductor rod in direct electrical communication and direct mechanical communication with the resistance wire; and a second conductor rod partially disposed within said retaining sheath and extending beyond the second end of the retaining sheath, the second conductor rod in direct electrical communication and direct mechanical communication with the resistance wire. The resistance wire, the first conductor rod and the second conductor rod comprise a circuit achieving a power to voltage rating of about 5000:24. | 03-15-2012 |
Stephen C. Evans, Westford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090205644 | PNEUMOSTOMA MANAGEMENT SYSTEM FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A pneumostoma management system for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. The pneumostoma vent includes a hydrophobic filter and/or a one-way valve. | 08-20-2009 |
| 20090205645 | PNEUMOSTOMA MANAGEMENT METHOD FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A method for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. To use the system, the chest is first cleaned and the chest mount secured to the chest adjacent the pneumostoma. The pneumostoma vent is then inserted into the pneumostoma through an aperture in the chest mount until it is engaged and secured by a coupling of the chest mount. The pneumostoma vent may be replaced periodically such as daily. The chest mount may be changed less frequently such as weekly. | 08-20-2009 |
| 20090205647 | PNEUMOSTOMA MANAGEMENT SYSTEM HAVING A COSMETIC AND/OR PROTECTIVE COVER - A pneumostoma management system which includes a pneumostoma management device and a cover. The pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a hydrophobic filter and/or a one-way filter. The cover serves to protect the pneumostoma management device and/or provide a cosmetic skin to make the pneumostoma management device more acceptable to the patient and thereby encourage patient compliance with a pneumostoma treatment regimen. | 08-20-2009 |
| 20090205651 | ONE-PIECE PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. The flange is formed in one piece with the tube. | 08-20-2009 |
| 20100174139 | Guide Wire Insertion and Re-Insertion Tools and Methods of Use - An insertion tool for use in inserting a guide wire into a guide wire lumen of a catheter for use in a lumen of an endoscope. The insertion tool includes a main body having a main lumen and a funnel-shaped extension connected to and disposed atop the main body. The funnel-shaped extension having a funnel lumen. The funnel lumen has a top opening and a bottom opening. The funnel lumen tapering from the top opening to the bottom opening. The bottom opening positioned and sized to communicate with the guide wire lumen of the catheter such that, when the catheter is disposed in the main lumen, the guide wire may be easily inserted into the top opening of the funnel lumen and into the guide wire lumen of the catheter. | 07-08-2010 |
Steve Evans, Westford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100030018 | ARTICULATING SURGICAL DEVICE - A surgical device for performing surgery generally includes a handle assembly, an elongate member extending from the handle assembly, an articulation mechanism operatively associated with the handle assembly, and an end effector. The elongate member has an articulating section and straight section. The articulating section is configured to articulate with respect to the straight section. The articulation mechanism is operatively associated with the handle assembly and the articulating section such that the articulating section articulates toward a first direction relative to the straight section upon movement of the handle assembly towards the first direction with respect to the straight section. The end effector is operatively coupled to the articulating section of the elongate member and includes first and second jaw members. The surgical device further includes a locking mechanism configured for fixing a relative position of first and second jaw members. | 02-04-2010 |
| 20110184459 | Articulating Surgical Device - An articulation mechanism for a surgical instrument includes an articulation assembly, a plurality of cables, and a trigger. The cables are coupled to the articulation assembly at a proximal end thereof and extend distally therefrom. The cables are configured to engage an end effector assembly of the surgical instrument at a distal end thereof. The trigger is coupled to the articulation assembly and is selectively moveable from a shipping position to a use position. In the shipping position, the cables are substantially un-tensioned. In the use position, the cables are disposed in an initial tensioned position. In the use position, the trigger is moveable between an unlocked position and a locked position. In the unlocked position, the cables are selectively tensionable to articulate the end effector assembly. In the locked position, the tensions on the cables are maintained to lock the end effector assembly in position. | 07-28-2011 |
Thomas C. Evans, Topsfield, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090035814 | Method for producing circular or multimeric protein species in vivo or in vitro and related methods - A method is disclosed for forming multimeric proteins. The method relies on intermolecular trans-splicing of a split intein either in vivo or in vitro. | 02-05-2009 |
| 20110201056 | Repair of Nucleic Acids for Improved Amplification - Methods and compositions are provided for repairing a polynucleotide so that it can be synthesized efficiently with improved fidelity and yield in, for example, an amplification reaction. This involves the use of a reaction mixture that includes a ligase and a cofactor selected from NAD+ or ATP and incubating the polynucleotide with the reaction mixture in the absence of Endonuclease VI. | 08-18-2011 |